A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept

NCT07419178 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
265
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Azienda Ospedaliero-Universitaria di Parma